ID: ALA4218509
Chembl Id: CHEMBL4218509
PubChem CID: 145968247
Max Phase: Preclinical
Molecular Formula: C21H26O3
Molecular Weight: 326.44
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C/C=C/CCCCc2ccc(O)cc2)cc1OC
Standard InChI: InChI=1S/C21H26O3/c1-23-20-15-12-18(16-21(20)24-2)9-7-5-3-4-6-8-17-10-13-19(22)14-11-17/h5,7,10-16,22H,3-4,6,8-9H2,1-2H3/b7-5+
Standard InChI Key: WEUBYUXOOVDPJD-FNORWQNLSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 326.44 | Molecular Weight (Monoisotopic): 326.1882 | AlogP: 4.92 | #Rotatable Bonds: 9 |
| Polar Surface Area: 38.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 10.31 | CX Basic pKa: ┄ | CX LogP: 5.75 | CX LogD: 5.75 |
| Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.52 | Np Likeness Score: 0.96 |
| 1. McLane RD, Le Cozannet-Laidin L, Boyle MS, Lanzillotta L, Taylor ZL, Anthony SR, Tranter M, Onorato AJ.. (2018) Synthesis and PGE2 inhibitory activity of novel diarylheptanoids., 28 (3): [PMID:29290543] [10.1016/j.bmcl.2017.12.046] |
Source(1):
